NRG-GI001
Terminated
Protocol Information
Tab containing protocol details, study design, and eligibility criteria
Tab containing study documents, informed consent forms, and study materials
Tab containing information for potential study participants
Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma
Principal Investigator
Status
Terminated
Open to Accrual
September 2, 2014
Open to Accrual
September 29, 2014
Temporarily Closed to Accrual
August 24, 2015
Open to Accrual
April 10, 2017
Closed to Accrual
July 2, 2018
Closed to Accrual & Treatment
July 2, 2018
Terminated
July 2, 2018
Disease Site
Gastrointestinal [GI] Liver
Phase
III
Developmental Therapeutics
No
Primary Objective
To evaluate the addition of liver-directed radiation therapy to chemotherapy with respect to overall survival (OS) for patients with unresectable, localized intrahepatic cholangiocarcinoma
Patient Population
Pathologically (histologically or cytologically) proven diagnosis of IHC without distant extrahepatic metastasis
Target Accrual
182
Protocol Documents
Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.
-
Share this study.
-
-
-
-
